India, June 5 -- On February 28, 2026, in the historic city of Ajmer, Rajasthan, a decisive shot was fired against a silent killer. When the nationwide Human Papillomavirus (HPV) vaccination campaign was launched, it marked the end of a 16-year policy hiatus. Targeting approximately 1.2 crore girls aged 14-year-olds as a priority cohort, the programme aims to dismantle the reign of cervical cancer-a disease that claims an Indian woman's life roughly every seven minutes.

As the "intensive" 90-day launch phase reaches its crescendo this May, the programme stands at a critical crossroads. While the science is settled and the logistics are in motion, convincing parents remains the final, most formidable frontier.

The U-WIN digital platform-...